Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
EUDA Health Holdings Limited (EUDA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/14/2025: EUDA (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $6
1 Year Target Price $6
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -23.74% | Avg. Invested days 28 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 126.90M USD | Price to earnings Ratio 168 | 1Y Target Price 6 |
Price to earnings Ratio 168 | 1Y Target Price 6 | ||
Volume (30-day avg) 1 | Beta -0.15 | 52 Weeks Range 1.03 - 6.30 | Updated Date 10/14/2025 |
52 Weeks Range 1.03 - 6.30 | Updated Date 10/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.02 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 5.17% | Operating Margin (TTM) -37.03% |
Management Effectiveness
Return on Assets (TTM) -63.92% | Return on Equity (TTM) - |
Valuation
Trailing PE 168 | Forward PE 12.12 | Enterprise Value 78650030 | Price to Sales(TTM) 24.59 |
Enterprise Value 78650030 | Price to Sales(TTM) 24.59 | ||
Enterprise Value to Revenue 19.34 | Enterprise Value to EBITDA -25.9 | Shares Outstanding 37767861 | Shares Floating 18403184 |
Shares Outstanding 37767861 | Shares Floating 18403184 | ||
Percent Insiders 49.6 | Percent Institutions 2.23 |
Upturn AI SWOT
EUDA Health Holdings Limited
Company Overview
History and Background
EUDA Health Holdings Limited is focused on providing medical and aesthetic solutions. While specific founding details and milestones are limited in publicly available sources, it appears to be a relatively newer entity aiming to innovate within the healthcare and aesthetics sectors.
Core Business Areas
- Medical Solutions: Likely involves the development and distribution of medical devices, pharmaceuticals, or diagnostic tools. Specific details are unclear due to limited information.
- Aesthetic Solutions: Focuses on products and services related to cosmetic procedures, skincare, or other aesthetic enhancements. Specific details are unclear due to limited information.
Leadership and Structure
Detailed information about the leadership team and organizational structure is limited in readily available sources.
Top Products and Market Share
Key Offerings
- Product/Service 1: Insufficient information to provide a specific product description, market share, competitors, or revenue data. Company information is generally unavailable. Competitors cannot be defined.
- Product/Service 2: Insufficient information to provide a specific product description, market share, competitors, or revenue data. Company information is generally unavailable. Competitors cannot be defined.
Market Dynamics
Industry Overview
The medical and aesthetic solutions industry is characterized by continuous innovation, evolving consumer demands, and stringent regulatory oversight. Growth is driven by an aging population, increased awareness of health and beauty, and technological advancements.
Positioning
Due to lack of specific information, EUDA Health Holdings Limited's position is uncertain. Its success depends on its ability to differentiate itself through innovative offerings and strategic partnerships.
Total Addressable Market (TAM)
The global medical aesthetics market is projected to reach hundreds of billions USD. EUDA's positioning relative to this TAM is indeterminate due to a lack of data.
Upturn SWOT Analysis
Strengths
- Potential for innovation in medical aesthetics
- Focus on emerging market segments
- Adaptable business model (speculative)
Weaknesses
- Limited brand recognition
- Dependence on initial capital and funding
- Limited information transparency and historical performance data
- Unclear market positioning and competitive advantages
Opportunities
- Expanding into new geographic markets
- Strategic partnerships with established players
- Leveraging technological advancements
- Capitalizing on the growing demand for non-invasive procedures
Threats
- Intense competition from established companies
- Regulatory hurdles and compliance costs
- Rapid technological advancements
- Economic downturns affecting consumer spending
- Lack of financial information and analyst coverage
Competitors and Market Share
Key Competitors
Competitive Landscape
Insufficient data to perform market share comparison.
Growth Trajectory and Initiatives
Historical Growth: Insufficient data available to discuss EUDA Health Holdings Limited's growth trends over the past years.
Future Projections: No analyst estimates available for future growth.
Recent Initiatives: Insufficient data available to highlight recent strategic initiatives undertaken by EUDA Health Holdings Limited.
Summary
EUDA Health Holdings Limited is a relatively unknown company with a focus on medical and aesthetic solutions. Due to limited information, it's challenging to assess the company's strength and potential. Its success hinges on securing funding, establishing a strong brand, and demonstrating technological innovation. The company needs to address transparency and financial reporting issues to attract investors.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (if available)
- Industry reports (general)
- News articles (if available)
Disclaimers:
The information provided is based on limited publicly available data and should not be considered investment advice. All investment decisions should be made in consultation with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About EUDA Health Holdings Limited
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2021-12-14 | CEO & Executive Director Mr. Alfred Lim | ||
Sector Real Estate | Industry Real Estate Services | Full time employees 117 | Website https://eudahealth.com |
Full time employees 117 | Website https://eudahealth.com | ||
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provides property management services. The company is headquartered in Singapore.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.